SLNOW
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
SLNOW
Delisted
SLNOW was delisted on the 8th of November, 2019.
5 hedge funds and large institutions have $124K invested in Soleno Therapeutics, Inc. Series A Warrant in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VC
1
Vivo Capital
Palo Alto,
California
|
$112K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$6K |
| 3 |
VF
3
Virtu Financial
New York
|
$1K |
Top Sellers
| 1 |
TSS
1
Two Sigma Securities
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $112K | 943,858 | +943,858 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $6K | 52,091 | +42,794 | +460% |
|
3
Hudson Bay Capital Management
Stamford,
Connecticut
| $4K | 30,000 | – | – |
|
|
BG
4
Bollard Group
Boston,
Massachusetts
| $1K | 10,985 | – | – |
|
|
VF
5
Virtu Financial
New York
| $1K | 12,516 | +12,516 | New |
|
|
TSS
6
Two Sigma Securities
New York
| – | – | -13,529 | Closed |
|